JP2023550840A5 - - Google Patents

Info

Publication number
JP2023550840A5
JP2023550840A5 JP2023532331A JP2023532331A JP2023550840A5 JP 2023550840 A5 JP2023550840 A5 JP 2023550840A5 JP 2023532331 A JP2023532331 A JP 2023532331A JP 2023532331 A JP2023532331 A JP 2023532331A JP 2023550840 A5 JP2023550840 A5 JP 2023550840A5
Authority
JP
Japan
Prior art keywords
quinazoline
fluorophenyl
alkyl
methyl
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023532331A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023550840A (ja
JP7844468B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/083141 external-priority patent/WO2022112490A1/en
Publication of JP2023550840A publication Critical patent/JP2023550840A/ja
Publication of JP2023550840A5 publication Critical patent/JP2023550840A5/ja
Application granted granted Critical
Publication of JP7844468B2 publication Critical patent/JP7844468B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023532331A 2020-11-27 2021-11-26 P2x3阻害剤としてのアミノキナゾリン誘導体 Active JP7844468B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20210189.5 2020-11-27
EP20210189 2020-11-27
PCT/EP2021/083141 WO2022112490A1 (en) 2020-11-27 2021-11-26 Amino quinazoline derivatives as p2x3 inhibitors

Publications (3)

Publication Number Publication Date
JP2023550840A JP2023550840A (ja) 2023-12-05
JP2023550840A5 true JP2023550840A5 (cg-RX-API-DMAC7.html) 2024-11-29
JP7844468B2 JP7844468B2 (ja) 2026-04-13

Family

ID=73642588

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023532331A Active JP7844468B2 (ja) 2020-11-27 2021-11-26 P2x3阻害剤としてのアミノキナゾリン誘導体

Country Status (10)

Country Link
US (1) US20240025880A1 (cg-RX-API-DMAC7.html)
EP (1) EP4251620B1 (cg-RX-API-DMAC7.html)
JP (1) JP7844468B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230113309A (cg-RX-API-DMAC7.html)
CN (1) CN116601149A (cg-RX-API-DMAC7.html)
AU (1) AU2021388923A1 (cg-RX-API-DMAC7.html)
CA (1) CA3196333A1 (cg-RX-API-DMAC7.html)
ES (1) ES3026309T3 (cg-RX-API-DMAC7.html)
MX (1) MX2023005803A (cg-RX-API-DMAC7.html)
WO (1) WO2022112490A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2026517300A (ja) 2023-05-22 2026-05-28 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ P2x3阻害剤を調製するための方法および中間体

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2596706T3 (es) 2006-06-29 2017-01-11 F. Hoffmann-La Roche Ag Arilamidas con sustitución de tetrazol
WO2008123963A1 (en) 2007-04-02 2008-10-16 Renovis, Inc. Pyrid-2-yl fused heterocyclic compounds, and compositions and uses thereof
US8076345B2 (en) 2007-04-17 2011-12-13 Evotec Ag 2-cyanophenyl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine compounds, compositions and uses thereof
WO2009110985A2 (en) 2008-02-29 2009-09-11 Renovis, Inc. Amide compounds, compositions and uses thereof
US20110237578A1 (en) 2008-09-18 2011-09-29 Zhi-Liang Wei Amide compounds, compositions and uses thereof
WO2016084922A1 (ja) 2014-11-28 2016-06-02 塩野義製薬株式会社 1,2,4-トリアジン誘導体およびその医薬組成物
WO2016088838A1 (ja) 2014-12-04 2016-06-09 塩野義製薬株式会社 プリン誘導体およびその医薬組成物
CU24411B1 (es) 2014-12-09 2019-05-03 Bayer Ag Compuesto derivado de benzamida sustituida con 1,3-tiazol-2-ilo útil para el tratamiento de trastornos neurogénicos
WO2017011729A1 (en) 2015-07-16 2017-01-19 Patara Pharma, LLC Combination therapies for the treatment of lung diseases
CA2998742C (en) 2015-09-29 2023-08-29 Anthony P. FORD Diaminopyrimidine p2x3 and p2x2/3 receptor modulators for use in the treatment of cough
MA56022A (fr) * 2019-05-31 2022-04-06 Chiesi Farm Spa Dérivés d'amino quinazoline servant d'inhibiteurs de p2x3

Similar Documents

Publication Publication Date Title
JP7767492B2 (ja) Glp-1受容体アゴニスト作用を持つピラゾロピリジン誘導体を含有する医薬組成物
JP3927175B2 (ja) N−置換ヒドロキシピリミジノンカルボキサミド系hivインテグラーゼ阻害薬
US5753666A (en) Quinolones and their therapeutic use
AU2012312305B2 (en) Acyclic cyanoethylpyrazoles as janus kinase inhibitors
CA2753434C (en) Soluble guanylate cyclase activators
JP7519221B2 (ja) 置換ピラゾロ[1,5-a]ピリミジンおよび医療疾患の治療におけるその使用
JP7013467B2 (ja) ウイルス感染の治療又は予防用の7位置換スルホンイミドイルプリノン化合物
JP5992615B2 (ja) 抗癌剤であるシクロプロパンカルボキサミドで置換された芳香族化合物
CA2602738C (en) Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof
TW202246232A (zh) Tyk2抑制劑及其用途
JP6755922B2 (ja) 新規な化合物、それらの調製及びそれらの使用
KR101053811B1 (ko) 6-(헤테로사이클-치환 벤질)-4-옥소퀴놀린 화합물 및 hiv 인테그라아제 억제제로서의 그의 용도
JP2021505684A (ja) ヒストンデアセチラーゼ6阻害剤としての1,2,4−オキサジアゾール誘導体
JP4540337B2 (ja) 新規4−アミノフロピリミジン化合物およびそれらの使用
JP2019510003A (ja) JAK阻害剤としてのピラゾロ[1,5−a]ピラジン−4−イル誘導体
JP2006502119A (ja) 新規2,5−二置換ピリミジン誘導体
JP2005537274A (ja) 4−アミノ置換ピリミジン誘導体
TW200845998A (en) Heterocyclic compounds useful in treating diseases and conditions
TW200410963A (en) Heterocyclic derivatives
JP2022502444A (ja) 3−アザビシクロ[3,1,1]ヘプタン誘導体及びこれを含む薬学的組成物
EP3860998A1 (en) Compounds and compositions for treating conditions associated with apj receptor activity
JP5411867B2 (ja) 新規sEH阻害剤およびそれらの使用
US11744824B2 (en) 2-amino-3-carbonyl imidazopyridine and pyrazolopyridine compounds
TW202504604A (zh) 小分子前列腺素f受體拮抗劑
ES2231439T3 (es) Derivados benzooxazol como inhibidores de tnf y de pde iv.